The next industrial revolution in India will be driven by biotechnology
Dr Jitendra Singh noted that the number of biotech startups has risen from just 50 in 2014 to over 5,000 now, reflecting India’s…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Dr Rajesh Jain
Panacea Biotec completes Phase I/II study of DengiAll, a tetravalent dengue vaccine candidate
The company has approached DGCI to seek accelerated review of its data to bring DengiAIl to market quickly
Making India a $100 bn biomanufacturing hub by 2024
Industry experts outline how Prime Minister Narendra Modi's dream of 'Make in India' for the biomanufacturing sector can be…
Panacea Biotec bags $24.32 m award from UN Agencies
The company received the award for its Easyfive-TT, which was introduced as fully liquid wP-based pentavalent vaccine in the…
Panacea Biotec announces launch of ViLACT for type 2 diabetes mellitus patients
It is a new oral anti-diabetic agent that enhances pancreatic islet cell responsiveness to glucose
IPA appoints Satish Reddy as President of IPA for 2019-2021
Dr Rajesh Jain will continue to be as the Vice President
Indian Pharmaceutical Alliance (IPA) recently announced the names of the…
Panacea Biotec gets PAHO order for supply of EasyFive-TT vaccines worth $13.49 mn
The company has been awarded for supply of 5.99 million doses of EasyfiveTT (DTP-HepB-Hib) fully liquid pentavalent vaccine for…